Table 3.

Presumptive shared QTL for healing on Chr 9, 10, and 11 in six crosses

Chr	QTL name	Peak Marker	Mb	Cross	Allele origin	Ref
9	Sth8	D9Mit207	60.4	MRL x SJL	MRL	(Masinde et al., 2001)
9	Sth9	D9Mit270	75.9	MRL x SJL	MRL	(Masinde et al., 2001)
9	Sth8 a		61.9	MRL x SJL	MRL	(Yu et al., 2007)
9	Sth9 a		87.3	MRL x SJL	MRL	(Yu et al., 2007)
9	Sth9 b		94.7	MRL x SJL	MRL	(Yu et al., 2007)
9	Heal14/Sth9	D9Mit182	101.4	MRL x CAST/Ei	Het, F>M	(Heber-Katz et al., 2004)
9	Sth8 b	D9Mit129	43.7	MRL x CAST/Ei	MRL	(Yu et al., 2005)
9	Sth9 b	D9Mit355	98.7	MRL x CAST/Ei	MRL	(Yu et al., 2005)
9	Chr 9a/Sth8a	D9Mit207	60	LG x SM	LG	current
9	Chr 9b/Sth9b	rs13480313/D9Mit12	85–98	LG x SM	LG	current
10	Heal 16	D10Mit170	48	LGXSM	SM	current
10	Chr 10b	rs8258353	86	LGXSM	SM	current
11	Heal10	D11Mit213	94.4	MRL x B6	MRL, M>F	(Blankenhorn et al., 2003)
11	Heal10	D11Mit100	110	MRL x CAST/Ei	MRL, M>F	(Heber-Katz et al., 2004)
11	Heal10	D11Mit101/D11Mit 122	83–92	LG x SM	LG/J, M>F	current
15	Heal4	D15Mit189	82.5	MRL x B6	MRL	(McBrearty et al., 1998)
15	Heal4?	rs13482628/D15Mit66	68–69	LG x SM	SM/J,M>F (d 15)	current

Designations are presented as found in the references (right column), except for QTL designated Sth8 and Sth9, where (a) and (b) are added to distinguish QTL that have been separated by subsequent analysis (Yu et al., 2007).